SCHEMBL8093202

SCHEMBL8093202

COc1ccccc1C1CC(=O)c2ccccc2O1

nearest known ligand 0.74

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 5/20 0.74
ADORA3 P0DMS8 3/20 0.63
AR P10275 2/20 0.63
HSD11B1 P28845 1/20 0.63
AKR1C3 P42330 1/20 0.63
MAOB P27338 4/20 0.63
MAPT P10636 3/20 0.63
NPC1 O15118 2/20 0.63
RAB9A P51151 2/20 0.63
KDM4E B2RXH2 3/20 0.59
HSD17B10 Q99714 3/20 0.59
ALDH1A1 P00352 2/20 0.58
HPGD P15428 1/20 0.58
AXL P30530 1/20 0.56
MAPK1 P28482 2/20 0.55
GAA P10253 1/20 0.55
ALOX15 P16050 1/20 0.55
TSHR P16473 1/20 0.55
CYP3A4 P08684 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8093207 1.00 CYP19A1 (0.74) CYP19A1ADORA3ARHSD11B1AKR1C3
SCHEMBL7032379 0.89 CYP19A1 (0.74) CYP19A1ADORA3ARHSD11B1AKR1C3
SCHEMBL7032375 0.89 CYP19A1 (0.74) CYP19A1ADORA3ARHSD11B1AKR1C3
SCHEMBL15951305 0.88 CYP19A1 (0.60) CYP19A1ADORA3ARHSD11B1AKR1C3
SCHEMBL4951987 0.84 AR (0.71) CYP19A1ADORA3ARHSD11B1AKR1C3
SCHEMBL15619210 0.84 CYP19A1 (0.59) CYP19A1ADORA3ARHSD11B1AKR1C3
SCHEMBL15619353 0.84 CYP19A1 (0.59) CYP19A1ADORA3ARHSD11B1AKR1C3
SCHEMBL8093300 0.81 ADORA3 (0.68) CYP19A1ADORA3ARHSD11B1AKR1C3
SCHEMBL8093292 0.81 ADORA3 (0.68) CYP19A1ADORA3ARHSD11B1AKR1C3
SCHEMBL28377827 0.79 CYP19A1 (0.65) CYP19A1ARMAOBMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6046231-A ADMINISTERING A SUFFICIENT AMOUNT OF A CANCER CHEMOPREVENTATIVE COMPOSITION COMPRISING 4'-BROMOFLAVONE TO A MAMMAL IN NEED TO PREVENT, DELAY OR REVERSE A CANCER SENSITIVE TO 4'-BROMOFLAVONE THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2000-04-04 US disclosed